Literature DB >> 25171900

Neurologic manifestations of gastrointestinal and liver diseases.

José M Ferro1, Sofia Oliveira.   

Abstract

Hepatic and gastrointestinal disorders can produce a wide spectrum of neurologic complications both affecting the central nervous system (CNS) and the peripheral nervous system. These manifestations range in severity from coma in acute liver failure and acute pancreatitis, to minor cognitive changes in chronic portosystemic encephalopathy and hepatitis C. Cerebrovascular diseases can complicate hepatitis C infection and inflammatory bowel disease. Demyelinating disorders may co-exist with inflammatory bowel disease. Anti-tumor necrosis factor alpha drugs may induce demyelination. Ataxia may occur in malabsorption syndromes and in gluten related disorders. Characteristic movement disorders are key features of acquired hepatocerebral degeneration and of Whipple disease. Multiple types of neuropathy can be found in association with hepatitis, inflammatory bowel disease and gluten related disorders.

Entities:  

Mesh:

Year:  2014        PMID: 25171900     DOI: 10.1007/s11910-014-0487-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  98 in total

1.  Opsoclonus-myoclonus associated with celiac disease.

Authors:  Nicolas Deconinck; Michèle Scaillon; Valérie Segers; José J Groswasser; Bernard Dan
Journal:  Pediatr Neurol       Date:  2006-04       Impact factor: 3.372

2.  MR imaging of central nervous system Whipple disease: a 15-year review.

Authors:  D F Black; A J Aksamit; J M Morris
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

Review 3.  Commonly used drugs in hematologic disorders.

Authors:  Elise Anderes; Sucha Nand
Journal:  Handb Clin Neurol       Date:  2014

4.  Wernicke encephalopathy presenting in a patient with severe acute pancreatitis.

Authors:  Ana Cecilia Arana-Guajardo; Carlos Rodrigo Cámara-Lemarroy; Erick Joel Rendón-Ramírez; Joel Omar Jáquez-Quintana; Juan Fernando Góngora-Rivera; Dionicio Angel Galarza-Delgado
Journal:  JOP       Date:  2012-01-10

Review 5.  Cerebral sinus venous thrombosis in inflammatory bowel diseases.

Authors:  A H Katsanos; K H Katsanos; M Kosmidou; S Giannopoulos; A P Kyritsis; E V Tsianos
Journal:  QJM       Date:  2012-12-12

6.  Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase.

Authors:  Marios Hadjivassiliou; Pascale Aeschlimann; Alexander Strigun; David S Sanders; Nicola Woodroofe; Daniel Aeschlimann
Journal:  Ann Neurol       Date:  2008-09       Impact factor: 10.422

7.  Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients.

Authors:  Elisa Maffeo; Anna Montuschi; Guido Stura; Maria Teresa Giordana
Journal:  Neurol Sci       Date:  2013-05-28       Impact factor: 3.307

8.  Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients.

Authors:  G R Oliveira; B C V Teles; E F Brasil; M H L P Souza; L E T A Furtado; C M de Castro-Costa; F H Rola; L L B C Braga; F de A A Gondim
Journal:  Inflamm Bowel Dis       Date:  2008-03       Impact factor: 5.325

9.  Cerebral thromboembolic events in pediatric patients with inflammatory bowel disease.

Authors:  A R Barclay; J M Keightley; I Horrocks; V Garrick; P McGrogan; R K Russell
Journal:  Inflamm Bowel Dis       Date:  2010-04       Impact factor: 5.325

10.  Cerebral Whipple's disease with a stroke-like presentation and cerebrovascular pathology.

Authors:  G Peters; D G du Plessis; P R Humphrey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-09       Impact factor: 10.154

View more
  11 in total

1.  Comprehensive analysis of patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody.

Authors:  Jia Liu; Li Xu; Zhuo-Lin Chen; Min Li; Huan Yi; Fu-Hua Peng
Journal:  Bosn J Basic Med Sci       Date:  2018-02-20       Impact factor: 3.363

2.  Iron and manganese-related CNS toxicity: mechanisms, diagnosis and treatment.

Authors:  Pan Chen; Melissa Totten; Ziyan Zhang; Hana Bucinca; Keith Erikson; Abel Santamaría; Aaron B Bowman; Michael Aschner
Journal:  Expert Rev Neurother       Date:  2019-02-21       Impact factor: 4.618

Review 3.  Structural brain lesions in inflammatory bowel disease.

Authors:  Can Dolapcioglu; Hatice Dolapcioglu
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 4.  Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.

Authors:  Adnan Malik; Rani Berry; Brian M Fung; James H Tabibian
Journal:  Clin J Gastroenterol       Date:  2020-11-04

Review 5.  Management of Neurologic Manifestations in Patients with Liver Disease.

Authors:  José M Ferro; Pedro Viana; Patrícia Santos
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.598

6.  Chronic inflammatory demyelinating polyneuropathy-like neuropathy as an initial presentation of Crohn's disease.

Authors:  Suji Kim; Seok-Jae Kang; Ki-Wook Oh; Byung Kyu Ahn; Hang Lak Lee; Dong Soo Han; Kiseok Jang; Young Seo Kim
Journal:  BMC Neurol       Date:  2015-03-28       Impact factor: 2.474

7.  Edema, Hyperpigmentation, Induration: 3 Skin Signs Heralding Danger in Patients on Maintenance Hemodialysis.

Authors:  Stefan Becker; Stefan Walter; Oliver Witzke; Andreas Körber; Anja Bienholz; Tanja Kottmann; Andreas Kribben; Gernot Kaiser; Anna Mitchell
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 8.  Organ-Organ Crosstalk and Alcoholic Liver Disease.

Authors:  Lauren G Poole; Christine E Dolin; Gavin E Arteel
Journal:  Biomolecules       Date:  2017-08-16

Review 9.  Peripheral neuropathy and gastroenterologic disorders: an overview on an underrecognized association.

Authors:  Carlotta Spagnoli; Francesco Pisani; Francesco Di Mario; Gioacchino Leandro; Federica Gaiani; Gian Luigi De' Angelis; Carlo Fusco
Journal:  Acta Biomed       Date:  2018-12-17

10.  Uncommon Movement Disorders in Chronic Hepatic Disease with Response to Rifaximin.

Authors:  Ana L Sousa; Paula Salgado; José E Alves; Sara Silva; Sofia Ferreira; Marina Magalhães
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.